Oncogenic loss of somatic ARID1A protein expression has been identified as an early molecular event during a transformation of endometriosis into cancer (from endometriosis to endometriosis-associated carcinoma in ovarian cancer and also from atypical endometrial hyperplasia to endometrioid adenocarcinoma in endometrial cancer). Here, ARID1A is linked to endometrial cancer.